Since we are unable to obtain synovial fluid and synovial tissue from individuals at risk of RA who do not yet present with arthritis, we are unable to directly verify our hypothesis of the protective effect of miR-451 mediated by CXCL16 on the development of RA at the site of inflammation in the synovium. The gene discussed is CXCL16; the disease is rheumatoid arthritis.